Passer au contenu principal

Chemical Entities of Biological Interest Ontology (CHEBI)

Choisissez le vocabulaire dans lequel chercher

aligner
annoter
télécharger

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > polyketide > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > polyketide > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > polyketide > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > macrocyclic lactone > macrolide > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > acetal > ketal > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > acetal > ketal > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > acetal > ketal > cyclic ketal > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > spiro compound > oxaspiro compound > spiroketal > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > polyketide > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > polyketide > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > polyketide > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > acetal > ketal > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > acetal > ketal > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > acetal > ketal > cyclic ketal > avermectin analogue > milbemycin > 5-Oxoavermectin ''2a'' aglycone

Terme préférentiel

5-Oxoavermectin ''2a'' aglycone  

Concept générique

Synonyme(s)

  • (1R,4S,4'S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20S,24S)-6'-butan-2-yl-4',12,24-trihydroxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,21-dione

Appartient au groupe

URI

http://data.loterre.fr/ark:/67375/KFP-BRM7VWVM-K

Télécharger ce concept :

RDF/XML TURTLE JSON-LD